SI3688468T1 - Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18 - Google Patents

Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18

Info

Publication number
SI3688468T1
SI3688468T1 SI201830693T SI201830693T SI3688468T1 SI 3688468 T1 SI3688468 T1 SI 3688468T1 SI 201830693 T SI201830693 T SI 201830693T SI 201830693 T SI201830693 T SI 201830693T SI 3688468 T1 SI3688468 T1 SI 3688468T1
Authority
SI
Slovenia
Prior art keywords
fgf
compound
predicting responsiveness
inflammatory biomarkers
biomarkers
Prior art date
Application number
SI201830693T
Other languages
English (en)
Slovenian (sl)
Inventor
Christoph H. Ladel
Hans Guehring
Anne-Christine Bay-Jensen
Morten Karsdal
Per Qvist
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SI3688468T1 publication Critical patent/SI3688468T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SI201830693T 2017-09-29 2018-09-28 Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18 SI3688468T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17194169 2017-09-29
EP18169317 2018-04-25
PCT/EP2018/076391 WO2019063756A1 (en) 2017-09-29 2018-09-28 INFLAMMATORY BIOMARKERS FOR PREDICTING REACTIVITY TO FGF-18 COMPOUND
EP18782012.1A EP3688468B1 (en) 2017-09-29 2018-09-28 Inflammatory biomarkers for predicting responsiveness to fgf-18 compound

Publications (1)

Publication Number Publication Date
SI3688468T1 true SI3688468T1 (sl) 2022-08-31

Family

ID=63722379

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201830693T SI3688468T1 (sl) 2017-09-29 2018-09-28 Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18

Country Status (16)

Country Link
US (2) US11467169B2 (cg-RX-API-DMAC7.html)
EP (1) EP3688468B1 (cg-RX-API-DMAC7.html)
JP (1) JP7418324B2 (cg-RX-API-DMAC7.html)
CN (1) CN111164429B (cg-RX-API-DMAC7.html)
AU (1) AU2018343980B2 (cg-RX-API-DMAC7.html)
CA (1) CA3075713A1 (cg-RX-API-DMAC7.html)
DK (1) DK3688468T3 (cg-RX-API-DMAC7.html)
ES (1) ES2918249T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20220737T1 (cg-RX-API-DMAC7.html)
HU (1) HUE058848T2 (cg-RX-API-DMAC7.html)
IL (1) IL273574B2 (cg-RX-API-DMAC7.html)
LT (1) LT3688468T (cg-RX-API-DMAC7.html)
PL (1) PL3688468T3 (cg-RX-API-DMAC7.html)
RS (1) RS63292B1 (cg-RX-API-DMAC7.html)
SI (1) SI3688468T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019063756A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2971315C (en) 2015-01-29 2023-02-14 Ares Trading S.A. Immunoassays for high positively charged proteins
LT3687558T (lt) 2017-09-29 2022-06-27 Merck Patent Gmbh Metaboliniai biožymenys, skirti atsako į fgf-18 junginį numatymui
RS63292B1 (sr) 2017-09-29 2022-06-30 Merck Patent Gmbh Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18
IL281333B2 (en) 2018-09-10 2025-11-01 Merck Patent Gmbh A method for reducing risk in a clinical trial

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75316C2 (uk) 1996-10-16 2006-04-17 Займодженетікс, Інк. Гомологи з фактором росту фібробласта
EP1551426B1 (en) 2002-10-07 2014-06-25 ZymoGenetics, Inc. Methods of administering fgf18
WO2004043237A2 (en) 2002-11-08 2004-05-27 Barnes-Jewish Hospital Uncoupled collagen synthesis and degradation assays
DK1828239T3 (da) 2004-12-10 2011-12-19 Zymogenetics Inc FGF18-produktion i prokaryote værter
US8224579B2 (en) 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
US8207115B2 (en) * 2006-08-25 2012-06-26 Ares Trading S.A. Treatment of cartilage disorders with FGF-18
JP2009257842A (ja) 2008-04-14 2009-11-05 Ttc:Kk 変形性関節症の検査方法及び診断用キット
US20100098775A1 (en) 2008-05-02 2010-04-22 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
US20090299769A1 (en) 2008-05-29 2009-12-03 Nordic Bioscience Imaging A/S Prognostic osteoarthritis biomarkers
US20120115137A1 (en) 2010-08-31 2012-05-10 Kornman Kenneth S Methods of Predicting Osteoarthritis
TWI527590B (zh) 2011-06-17 2016-04-01 艾瑞斯貿易公司 Fgf-18之凍乾調配物
EP2880179B1 (en) 2012-08-06 2017-12-13 Merck Patent GmbH Genetic markers for predicting responsiveness to fgf-18 compound
PL2880181T3 (pl) 2012-08-06 2019-03-29 Merck Patent Gmbh Biomarkery prognostyczne w zaburzeniach chrząstki
TW201536320A (zh) * 2013-12-02 2015-10-01 Abbvie Inc 治療骨性關節炎之組合物及方法
KR102434024B1 (ko) 2013-12-24 2022-08-22 아레스 트레이딩 에스.아. 알지네이트/콜라겐 히드로겔 중의 fgf-18 제형물
NZ721332A (en) 2013-12-24 2022-07-01 Ares Trading Sa Fgf-18 formulation in xyloglucan gels
ES2698117T3 (es) 2014-02-20 2019-01-31 Merck Patent Gmbh Implante que comprende FGF-18
KR102437057B1 (ko) 2014-02-20 2022-08-26 메르크 파텐트 게엠베하 이식편 이식 및 조직 공학 절차에 있어서의 fgf-18
HRP20181570T1 (hr) 2014-02-20 2018-11-30 Merck Patent Gmbh Režim doziranja spoja fgf-18
CA2971315C (en) 2015-01-29 2023-02-14 Ares Trading S.A. Immunoassays for high positively charged proteins
WO2017079759A1 (en) 2015-11-06 2017-05-11 Samumed, Llc 2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
US9983214B2 (en) 2016-04-15 2018-05-29 Esm Technologies, Llc Method for evaluating articular joint therapeutics
RS63292B1 (sr) 2017-09-29 2022-06-30 Merck Patent Gmbh Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18
LT3687558T (lt) 2017-09-29 2022-06-27 Merck Patent Gmbh Metaboliniai biožymenys, skirti atsako į fgf-18 junginį numatymui
IL281333B2 (en) 2018-09-10 2025-11-01 Merck Patent Gmbh A method for reducing risk in a clinical trial

Also Published As

Publication number Publication date
US12332250B2 (en) 2025-06-17
US20210231680A1 (en) 2021-07-29
ES2918249T3 (es) 2022-07-14
AU2018343980B2 (en) 2025-04-10
DK3688468T3 (da) 2022-06-20
JP7418324B2 (ja) 2024-01-19
CA3075713A1 (en) 2019-04-04
PL3688468T3 (pl) 2022-07-18
US20230258659A1 (en) 2023-08-17
EP3688468A1 (en) 2020-08-05
EP3688468B1 (en) 2022-03-16
WO2019063756A1 (en) 2019-04-04
CN111164429A (zh) 2020-05-15
AU2018343980A1 (en) 2020-04-02
JP2020535423A (ja) 2020-12-03
IL273574B1 (en) 2024-09-01
CN111164429B (zh) 2024-08-09
RS63292B1 (sr) 2022-06-30
US11467169B2 (en) 2022-10-11
LT3688468T (lt) 2022-06-27
HUE058848T2 (hu) 2022-09-28
IL273574B2 (en) 2025-01-01
HRP20220737T1 (hr) 2022-09-02
IL273574A (en) 2020-05-31

Similar Documents

Publication Publication Date Title
GB201609977D0 (en) Chemosensitivity predictive biomarkers
EP4119042C0 (en) TRANSCUTANEOUS ANALYTE SENSOR SYSTEMS
GB2511949B (en) Indirect branch prediction
GB2510966B (en) Indirect branch prediction
GB201320216D0 (en) Predicting call quality
IL273840A (en) Biomarker for senescent cells
EP3487868A4 (en) WASHING PAD FOR AFFINITY CHROMATOGRAPHY
EP3295474A4 (en) Stress control for heteroepitaxy
IL273574A (en) Inflammatory biomarkers for predicting response to FGF-18 compound
SG11201602195YA (en) Chromatography medium
PT3481964T (pt) Biomarcadores para doença inflamatória intestinal
IL273613A (en) Metabolic biomarkers for predicting response to FGF-18 compound
EP3036712A4 (en) Methods for predicting prognosis
EP3004267A4 (en) URETHANOUS COMPOSITION FOR METAL SUBSTRATE
ZA201706684B (en) Beta-hairpin peptidomimetics
GB201704267D0 (en) Novel biomarker
GB201705044D0 (en) Biomarker
EP3272876A4 (en) Method for predicting responsiveness to phosphatidylserine synthase 1 inhibitor
IL241063A0 (en) Observe for predictive biomarkers
GB2539420B (en) Determination of chromatography conditions
GB201306339D0 (en) Biomarkers for prognosis
FR3033460B1 (fr) Ensemble de refroidissement pour aeronef
EP3552010C0 (en) TEMPERATURE CONTROL SYSTEM FOR A CHROMATOGRAPHIC SYSTEM
PT3688468T (pt) Biomarcadores inflamatórios para prever a recetividade ao composto de fg-18
PT3687558T (pt) Biomarcadores metabólicos para prever a responsividade ao composto de fgf-18